Effects of Concurrent Aerobic and Resistance Training After Bariatric Surgery in Women: RCT
BARI-EX2023
The Effects of Concurrent Aerobic and Resistance Training on Body Composition and Metabolic Parameters in Women Following Sleeve Gastrectomy: A Randomized Controlled Trial
2 other identifiers
interventional
20
1 country
1
Brief Summary
The purpose of this study is to evaluate the effects of a 12-week exercise program on body composition and various physical and physiological parameters in patients who have undergone bariatric surgery. The exercise interventions include aerobic training and combined aerobic and resistance (strength) training. The study aims to determine the impact of these exercise approaches on post-operative recovery and overall physical fitness in this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 2, 2024
CompletedFirst Submitted
Initial submission to the registry
April 10, 2026
CompletedFirst Posted
Study publicly available on registry
April 17, 2026
CompletedApril 17, 2026
April 1, 2026
3 months
April 10, 2026
April 16, 2026
Conditions
Outcome Measures
Primary Outcomes (9)
Change in Body Mass Index (BMI)
BMI is calculated as weight in kilograms divided by the square of height in meters (kg/m2). It is used to assess the change in body mass relative to height following the 12-week exercise intervention.
Baseline and 12 weeks
Change in Body Lean Mass
Total body lean mass (fat-free mass) measured in kilograms (kg) using Bioelectrical Impedance Analysis (BIA). This measure assesses the preservation of muscle tissue during weight loss following the 12-week exercise intervention.
Baseline and 12 weeks
Change in Total Body Water
Total amount of water in the body, measured in kilograms ($kg$) using Bioelectrical Impedance Analysis (BIA). It reflects changes in hydration status and lean tissue composition.
Baseline and 12 weeks
Change in Basal Metabolic Rate (BMR)
The amount of energy expended daily by the body at rest, measured in kilocalories (kcal) via BIA. This measure evaluates the metabolic efficiency following the intervention.
Baseline and 12 weeks
Change in Metabolic Age
A calculated value based on BIA parameters that compares an individual's BMR to the average BMR of their age group, measured in years (years).
Baseline and 12 weeks
Change in Glycated Hemoglobin (HbA1c)
Measurement of average blood glucose levels over the past 2-3 months, recorded as a percentage (%). Venous blood samples are analyzed to evaluate long-term glycemic control.
Baseline and 12 weeks
Change in Serum C-Peptide Levels
Measurement of C-peptide levels in the blood (ng/mL) as an indicator of endogenous insulin production and pancreatic beta-cell function.
Baseline and 12 weeks
Change in Serum Uric Acid
Measurement of uric acid concentration in the blood (mg/dL), used to monitor metabolic health and risk of hyperuricemia post-surgery.
Baseline and 12 weeks
Change in Blood Urea Levels
Measurement of urea concentration in the blood ($mg/dL$) to evaluate kidney function and protein metabolism during the intervention period.
Baseline and 12 weeks
Study Arms (2)
Aerobic Training Group
EXPERIMENTALParticipants in this group perform 12 weeks of structured aerobic exercise for 3 sessions per week. Each session lasts approximately 45-60 minutes at a moderate intensity.
Combined Training Group
EXPERIMENTALParticipants in this group perform 12 weeks of combined aerobic and resistance (strength) training for 3 sessions per week. The program includes both moderate-intensity aerobic exercise and resistance exercises targeting major muscle groups (2-3 sets of 8-12 repetitions).
Interventions
The aerobic exercise intervention is a supervised 12-week program conducted 3 sessions per week. Each session lasts approximately 45-60 minutes and consists of: 1) A 5-10 minute warm-up period at low intensity, 2) 30-40 minutes of moderate-intensity aerobic activity (treadmill walking or stationary cycling) targeted at 60-70% of the heart rate reserve (HRR), and 3) A 5-10 minute cool-down period. Exercise intensity is continuously monitored using heart rate monitors to ensure compliance and adherence to the prescribed intensity zones.
Supervised resistance training including 2-3 sets of 8-12 repetitions at 60-80% of 1RM targeting major muscle groups
Eligibility Criteria
You may qualify if:
- Age between 18-65 years
- Sleeve gastrectomy performed at least 3 months prior to enrollment
- Medical clearance for participation in exercise
- No history of lower extremity injury within the past year
- Ability to perform cycling and running exercises
You may not qualify if:
- Medical contraindications to exercise participation
- Surgery performed more than 1 year prior to enrollment
- Presence of neurological, hormonal, cardiovascular, or respiratory disorders within the past year
- Lower extremity muscle or joint discomfort within the past 6 months
- Voluntary withdrawal from the study
- Occurrence of adverse events during the study
- Failure to attend ≥2 consecutive sessions per week or ≥20% of total sessions during the 12-week intervention period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gazi Universitylead
Study Sites (1)
Gazi University, Faculty of Sport Sciences
Ankara, Ankara, 06560, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mehmet Günay, Prof.Dr.
Gazi University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.Dr.
Study Record Dates
First Submitted
April 10, 2026
First Posted
April 17, 2026
Study Start
September 2, 2024
Primary Completion
November 25, 2024
Study Completion
December 2, 2024
Last Updated
April 17, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared to protect participant privacy and maintain confidentiality, in accordance with the protocols approved by the Institutional Ethics Committee. Study results will be made available through peer-reviewed publications